Bellevue Asset Management (Switzerland)’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	$890K	Hold	40,000	–	–	0.14%	103
2015 Q3	$944K	Buy	40,000 +13,000	+48%	+$307K	0.15%	107
2015 Q2	$2.21M	Buy	+27,000	New	+$2.21M	0.31%	80